PROCTER & GAMBLE HEALTH | PARABOLIC DRUGS | PROCTER & GAMBLE HEALTH/ PARABOLIC DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 37.3 | -1.8 | - | View Chart |
P/BV | x | 10.8 | - | - | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH PARABOLIC DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
PARABOLIC DRUGS Mar-18 |
PROCTER & GAMBLE HEALTH/ PARABOLIC DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 10 | 54,695.2% | |
Low | Rs | 3,883 | 6 | 64,501.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 11.8 | 6,266.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | -9.3 | -1,486.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -5.8 | -2,670.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | -142.4 | -314.3% | |
Shares outstanding (eoy) | m | 16.60 | 61.89 | 26.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.7 | 932.3% | |
Avg P/E ratio | x | 33.5 | -0.9 | -3,929.7% | |
P/CF ratio (eoy) | x | 29.8 | -1.4 | -2,187.6% | |
Price / Book Value ratio | x | 10.3 | -0.1 | -18,585.8% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 490 | 15,669.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 98 | 2,096.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 732 | 1,680.8% | |
Other income | Rs m | 184 | 42 | 442.2% | |
Total revenues | Rs m | 12,480 | 773 | 1,614.2% | |
Gross profit | Rs m | 3,247 | -291 | -1,117.2% | |
Depreciation | Rs m | 281 | 216 | 130.2% | |
Interest | Rs m | 8 | 93 | 8.3% | |
Profit before tax | Rs m | 3,142 | -558 | -563.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 18 | 4,814.2% | |
Profit after tax | Rs m | 2,295 | -575 | -398.7% | |
Gross profit margin | % | 26.4 | -39.7 | -66.5% | |
Effective tax rate | % | 27.0 | -3.2 | -854.8% | |
Net profit margin | % | 18.7 | -78.7 | -23.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 737 | 1,588.7% | |
Current liabilities | Rs m | 6,791 | 3,942 | 172.3% | |
Net working cap to sales | % | 40.0 | -438.1 | -9.1% | |
Current ratio | x | 1.7 | 0.2 | 922.2% | |
Inventory Days | Days | 263 | 1 | 37,089.7% | |
Debtors Days | Days | 343 | 144 | 238.8% | |
Net fixed assets | Rs m | 10,617 | 3,330 | 318.8% | |
Share capital | Rs m | 166 | 619 | 26.8% | |
"Free" reserves | Rs m | 7,265 | -9,432 | -77.0% | |
Net worth | Rs m | 7,431 | -8,813 | -84.3% | |
Long term debt | Rs m | 0 | 8,352 | 0.0% | |
Total assets | Rs m | 22,330 | 4,089 | 546.0% | |
Interest coverage | x | 409.1 | -5.0 | -8,181.0% | |
Debt to equity ratio | x | 0 | -0.9 | -0.0% | |
Sales to assets ratio | x | 0.6 | 0.2 | 307.8% | |
Return on assets | % | 10.3 | -11.8 | -87.4% | |
Return on equity | % | 30.9 | 6.5 | 473.0% | |
Return on capital | % | 42.4 | 100.9 | 42.0% | |
Exports to sales | % | 0 | 22.0 | 0.0% | |
Imports to sales | % | 13.1 | 2.6 | 500.9% | |
Exports (fob) | Rs m | NA | 161 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 19 | 8,418.5% | |
Fx inflow | Rs m | 1,465 | 161 | 910.6% | |
Fx outflow | Rs m | 1,605 | 20 | 8,035.0% | |
Net fx | Rs m | -140 | 141 | -99.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 31 | 7,694.8% | |
From Investments | Rs m | -215 | 9 | -2,491.3% | |
From Financial Activity | Rs m | -985 | -37 | 2,659.2% | |
Net Cashflow | Rs m | 1,160 | 2 | 51,114.5% |
Indian Promoters | % | 0.0 | 37.1 | - | |
Foreign collaborators | % | 51.8 | 0.7 | 7,098.6% | |
Indian inst/Mut Fund | % | 20.0 | 8.6 | 231.1% | |
FIIs | % | 6.2 | 8.1 | 77.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 62.2 | 77.4% | |
Shareholders | 56,778 | 13,652 | 415.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | PARABOLIC DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.56% | -4.84% | 0.58% |
1-Month | 2.61% | 26.11% | 3.13% |
1-Year | -4.47% | 141.53% | 55.61% |
3-Year CAGR | -6.27% | -11.38% | 13.89% |
5-Year CAGR | 1.20% | -6.58% | 21.73% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the PARABOLIC DRUGS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of PARABOLIC DRUGS the stake stands at 37.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of PARABOLIC DRUGS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
PARABOLIC DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of PARABOLIC DRUGS.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.